$1275 | SAVE $225 | Single User
$2125 | SAVE $375 | Multi User

Global Pneumonia Vaccine Market Outlook 2020

Global Pneumonia Vaccine Market Outlook 2020
[Lowest Price Guaranteed: $1,275]

Published by RNCOS: 01 Jun 2015 | 24748 | In Stock
Related Topics: GlaxoSmithKline , Pfizer , Pneumonia , Vaccine

Introduction

According to a new research, introduction of the 10-valent pneumococcal conjugate vaccine, PCV10, decreases the rates of clinical pneumonia even in unvaccinated children, a classic example of herd immunity. With a greater number of serotypes in current vaccines, there has been more disease reduction in both vaccinated and unvaccinated populations. As vaccines evolve, similar improvements can be expected.

According to our report, “Global Pneumonia Vaccine Market Outlook 2020”, the Pneumonia vaccine market for 2014, which has been estimated at US$ 5.9 Billion, is expected to reach US$ 11 Billion by 2020, growing at a CAGR of 11.1% over the six year period. The report offers a clear and succinct take on the current Pneumococcal Vaccine Industry. The current market and future forecasts for the industry have been derived. The regional distribution of the current market has also been discussed. It has been noted that although USA and Europe are the major shareholders in the market, the developing regions are expected to account for a significant share too. This shift can be attributed to the rising incidences as well as the increasing purchasing power of the populations in these regions. Government’s focus on a preventive healthcare strategy to cut down costs is also set to play a major role in the growth of the vaccine industry.

As vaccines are highly regulated to ensure patients and users have access to safe and effective medicines, the regulatory scenarios for vaccine approval and licensing has also been discussed. It has been noted that individual governments determine which products can be marketed in their countries and many have state-regulated systems governing product pricing.

Lastly, the report discusses the three major players in the industry viz., GlaxoSmithKline, Pfizer and Merck. The competitive landscape is supplemented with a chapter highlighting the current share of every player in the market. This is followed by company profiles, wherein the general business along with key financials of every player has been provided. At the end of every profile, a strength and weakness analysis has been performed. The report provides a prudent analysis of the market and is a must have supplement for any player interested in the industry.

Table of Contents
for Global Pneumonia Vaccine Market Outlook 2020

  • 1. Analyst View

    2. Research Methodology

    3. Pneumococcal Disease and Vaccine

    4. Global Pneumonia Vaccine Market Outlook 2020

    4.1 Key Geographical Markets

    5. Regulatory Overview

    5.1 United States

    5.2 Europe

    5.3 Rest of the World

    5.3.1 India

    5.3.2 China

    5.3.3 Japan

    6. Competitive Assessment

    6.1 Market Share of Major Players

    6.2 Company Profiles

    6.2.1 GlaxoSmithKline

    6.2.1.1 Business Overview

    6.2.1.2 Key Financials

    6.2.1.3 Strengths and Weaknesses

    6.2.2 Pfizer

    6.2.2.1 Business Overview

    6.2.2.2 Key Financials

    6.2.2.3 Strengths and Weaknesses

    6.2.3 Merck

    6.2.3.1 Business Overview

    6.2.3.2 Key Financials

    6.2.3.3 Strengths and Weaknesses

    List of Figures:

    Figure 4-1: Relation between Country Income and Under-5 Child Deaths from Pneumonia

    Figure 4-2: Impact of Childhood Conjugate Pneumococcal Immunization on Incidence of Disease in < 5 Years of Age

    Figure 4-3: Herd Immunity Impact of Childhood Pneumococcal Immunization in the US

    Figure 4-4: Pneumonia Vaccine Market (Million US$), 2009-2014

    Figure 4-5: Pneumonia Vaccine Market (Million Doses), 2009-2014

    Figure 4-6: Pneumonia Vaccine Market (Million US$), 2014-2020

    Figure 4-7: Pneumococcal Vaccine Market by Geography (%), 2014

    Figure 4-8: Percentage of Adults Aged 65 and over who had ever received a Pneumococcal Vaccination: United States, 1997-2013

    Figure 4-9: Age-Adjusted Death Rates for Pneumonia in 2013: United States, 1999-2013

    Figure 6-1: Pneumococcal Vaccine Market Value Share by Players (%), 2014

    Figure 6-2: Pneumococcal Vaccine Market Volume Share by Players (%), 2014

    Figure 6-3: GSK - Revenue by Geographic Segment (%), 2014

    Figure 6-4: GSK - Revenue by Business Segment (%), 2014

    Figure 6-5: GSK - Break-up of Revenue of Pharmaceutical and Vaccines Business Segment (%), 2014

    Figure 6-6: GSK - Synflorix Sales (Million GBP), 2010-2014

    Figure 6-7: Pfizer - Revenue by Geography (%), 2014

    Figure 6-8: Pfizer - Revenue by Business Segment (%), 2014

    Figure 6-9: Pfizer - Prevnar Family Sales (Million USD), 2010-2014

    Figure 6-10: Merck - Revenue by Business Segment (%), 2014

    Figure 6-11: Merck - Revenue by Geography (%), 2014

    Figure 6-12: Merck - Pneumovax 23 Sales (Million USD), 2010-2014

    List of Tables:

    Table 4-1: Current levels of coverage for interventions that prevent (vaccination) Pneumonia

    Table 6-1: GSK - Pneumonia Vaccine Portfolio

    Table 6-2: GSK - Key Financials (Million GBP), 2012-2014

    Table 6-3: GSK - Strengths and Weaknesses

    Table 6-4: Pfizer - Pneumonia Vaccine Portfolio

    Table 6-5: Pfizer - Key Financials (Million US$), 2012-2014

    Table 6-6: Pfizer - Strengths and Weaknesses

    Table 6-7: Merck - Pneumonia Vaccine Portfolio

    Table 6-8: Merck - Key Financials (Millions US$), 2012-2014

    Table 6-9: Merck - Strengths and Weaknesses

Additional Details

Publisher

RNCOS

Publisher Information

RNCOS is a Business Consulting Service firm providing multiple services to companies wishing to engage in any business expansion.



We uniquely position our self as a "one-stop-shop" offering a broad spectrum of Management Consulting and Business facilitation services including but not limited to Financial & Business Assessment, Market Entry / Expansion Strategies, Market and Industry Research, Identification & Selection of Business Partners, Feasibility and Facility Location Studies etc.



Since our inception in 2002, we have gained industry experience and expertise in offering research solutions to distinguished clientele' across multi geographies and industry verticals. We help our clients in achieving sustainable performance and better growth prospects by weeding out their obsolete business process with well laid strategies by working in close co-ordination with them.



Be it market entry, product testing, competition assessment, customer satisfaction study, pricing analysis or any other requirement, RNCOS team acts proactively to fit in the best possible solution for our valued clients. We believe in multi-level client interaction and complete transparency from the project commencement till effective implementation, thus ensuring total customer satisfaction.

Reference

24748 |

Number of Pages

50

Report Format

PDF

RNCOS Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Global Pneumonia Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Pneumonia Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016
Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical t...
30 Sep 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
About this ReportThis new 366-page report from VPG Market Research presents detailed analysis of the...
28 Jun 2016 by Venture Planning Group (VPG) USD $8,373 (normally
USD $9,851)
More Info
SAVE 15% today! France Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
About This ReportThis new 282-page report from VPG Market Research presents detailed analysis of the...
28 Jun 2016 by Venture Planning Group (VPG) USD $1,658 (normally
USD $1,951)
More Info
SAVE 15% today! Germany Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
About This ReportThis new 283-page report from VPG Market Research presents detailed analysis of the...
28 Jun 2016 by Venture Planning Group (VPG) USD $1,658 (normally
USD $1,951)
More Info
SAVE 15% today! Italy Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technolog Trends, Instrumentation Review
About This ReportThis new 281-page report from VPG Market Research presents detailed analysis of the...
28 Jun 2016 by Venture Planning Group (VPG) USD $1,658 (normally
USD $1,951)
More Info
SAVE 15% today! Japan Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
About This ReportThis new 282-page report from VPG Market Research presents detailed analysis of the...
28 Jun 2016 by Venture Planning Group (VPG) USD $2,040 (normally
USD $2,400)
More Info
SAVE 15% today! Spain Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
About This ReportThis new 281-page report from VPG Market Research presents detailed analysis of the...
28 Jun 2016 by Venture Planning Group (VPG) USD $1,658 (normally
USD $1,951)
More Info
SAVE 15% today! Pneumonia: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (Franc...
24 Jun 2016 by Venture Planning Group (VPG) USD $3,698 (normally
USD $4,351)
More Info

This report is published by RNCOS

RNCOS is a Business Consulting Service firm providing multiple services to companies wishing to engage in any business expansion.

We uniquely position our self as a "one-stop-shop" offering a broad spectrum of Management Consulting and Business facilitation services including but not limited to Financial & Business Assessment, Market Entry / Expansion Strategies, Market and Industry Research, Identification & Selection of Business Partners, Feasibility and Facility Location Studies etc.

Since our inception in 2002, we have gained industry experience and expertise in offering research solutions to distinguished clientele' across multi geographies and industry verticals. We help our clients in achieving sustainable performance and better growth prospects by weeding out their obsolete business process with well laid strategies by working in close co-ordination with them.

Be it market entry, product testing, competition assessment, customer satisfaction study, pricing analysis or any other requirement, RNCOS team acts proactively to fit in the best possible solution for our valued clients. We believe in multi-level client interaction and complete transparency from the project commencement till effective implementation, thus ensuring total customer satisfaction.

Download Free Report Summary PDF

Global Pneumonia Vaccine Market Outlook 2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...